IP Patent News » Court

Court affirms Eli Lilly patents protecting Evista – BusinessWeek

admin — Thu, 02 Sep 2010 04:48:40 +0000

Court affirms Eli Lilly patents protecting Evista
BusinessWeek
Eli Lilly and Co. said Wednesday a federal appeals court upheld patents protecting its osteoporosis treatment Evista, giving the drugmaker a victory after …
Lilly: Appeals court backs Evista method patentsMarketWatch
Appeals court ruling upholds Lilly’s Evista patentsIndianapolis Business Journal
U.S. Court of Appeals Upholds Validity of Lilly’s Evista Patents Through March …PR Newswire (press release)
Wall Street Journal

Full Federal Circuit Narrowly Applies Patent Misuse Doctrine

admin — Thu, 02 Sep 2010 03:23:04 +0000

[Story ID: 3543]

A divided U.S. Court of Appeals for the Federal Circuit has ruled that an anti-competitive agreement between two companies to restrict the availability of one of their patents in favor of two others is not misuse of the favored patents. Applying the patent misuse doctrine narrowly, the court determined that the patents at issue are enforceable. The case involves the technology for recordable …

Biopolymer Engineering and MIT Fail to Get Vacation (of Summary Judgment)

admin — Fri, 13 Aug 2010 15:27:41 +0000

[Story ID: 3397]

In a nonprecidential opionion, the U.S. Court of Appeals for the Federal Circuit dismissed an appeal by Biopolymer Engineering (Biothera) as moot after it appealed a District Court order granting summary judgment of noninfringement by Immunocorp and Biotec Pharmacon ASA (Biotec). Biopolymer Engineering and MIT v. Immunocorp and Biotec Pharmacon ASA (2010-1096). Biothera sued Biotec [...]

Related posts:Supreme Court Certiorari: Summary Dispositions of Classen and Prometheus The Supreme Court issued GVR Orders* on two important biotech…

Drugmakers Get Broader Protection From Generics After Court Says A Means Any

admin — Wed, 11 Aug 2010 20:03:17 +0000

[Story ID: 3382]

Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind. tried to get a rehearing en banc regarding the counterclaim provision of the Hatch-Waxman Act (HWA). Novo Nordisk A/S v. Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind., US Court of Appeals for the Federal Circuit (2010-1001). The petition for panel rehearing and for rehearing en banc was denied. [...]

Related posts:Supreme Court Certiorari: Summary Dispositions of Classen and Prometheus The Supreme Court issued GVR Orders* on two important biotech…
Structurally Similar Drug with Different Biological Properties Meets Criteria for Term Extension After the US Patent and Trademark Office denied a patent…
Drug Label Encouraging Infringing Use Shows Intent to Induce (Even if Prescribed for Noninfringing Use) A featured document in the Docket Report recently highlighted an…

Related posts brought to you by Yet Another Related Posts Plugin.

Eli Lilly Loses Method Patent After the Use Was Disclosed in an Earlier Patent

admin — Thu, 05 Aug 2010 21:03:58 +0000

[Story ID: 3369]

Eli Lilly lost an appeal from a final judgment of the U.S. District Court for the Eastern District of Michigan, finding claims 2, 6, and 7 of U.S. Patent No. 5,464,826 invalid for obviousness-type double patenting over its earlier U.S. Patent No. 4,808,614. See, Sun Pharmaceutical Industries v. Eli Lilly and Co., United States Court [...]

Related posts:Bilski: S.Ct Refuses to Prohibit Software, Business Method, and Medical Diagnostic Method Patents This morning, the Supreme Court issued its long awaited opinion…
Blinded By Science: Myriad Loses Breast Cancer Test Patents On March 29, 2010, the University of Utah and Myriad…
You Can’t Rely On Test Results That Weren’t Available When Your Patent Application Was Filed The U.S. Court of Appeals for the Federal Circuit upheld…

Related posts brought to you by Yet Another Related Posts Plugin.

Circuit Court Judge removes Amendment 9 from November ballot

admin — Sat, 31 Jul 2010 05:58:50 +0000

[Story ID: 3342]

Today, Circuit Court Judge James Shelfer removed Amendment 9′

Australian Patent Office Refines Test for Patentability of Business Methods

admin — Mon, 26 Jul 2010 16:14:41 +0000

[Story ID: 3249]

Hot on the heels of the Bilski decision in the US, the Australian Patent Office has now refined the Australian test for the patentability of business methods. The patent application in question relates to a ‘

Facebook Roundup: Zuck on TV, Lawsuits,Sarah Palin, Coca-Cola and More – Inside Facebook (blog)

admin — Sat, 24 Jul 2010 02:35:22 +0000

Facebook Roundup: Zuck on TV, Lawsuits,Sarah Palin, Coca-Cola and More
Inside Facebook (blog)
Facebook has been habitually taken to court over extremely broad prior patents, and these cases have tended to not go anywhere. …

and more

Bilski: One Word That Could Mean Big Bucks for the Patent Bar – Wall Street Journal (blog)

admin — Sat, 24 Jul 2010 01:38:07 +0000

Patent Baristas (blog)
Bilski: One Word That Could Mean Big Bucks for the Patent Bar
Wall Street Journal (blog)
Many feared the US Supreme Court would, in the Bilski case, knock a huge hole into so-called ‘

Federal Court Finds That Fairchild Semiconductor Willfully Infringed Power … – MarketWatch (press release)

admin — Sat, 24 Jul 2010 01:01:24 +0000

EETimes.com
Federal Court Finds That Fairchild Semiconductor Willfully Infringed Power …
MarketWatch (press release)
Fairchild was found to infringe four of the company’s patents following a jury trial in October 2006; the jury rejected Fairchild’s challenges to the …
Court Sides With Power Integrations in Patent CaseABC News

all 74 news articles